drugset / Trial / NCT00004446

Study of Fluoxetine in Patients With Depersonalization Disorder

NCT00004446

RandomizedDouble-blindTreatment

Summary

The purpose of this study is to: 1\) Determine the effects of fluoxetine in the treatment of depersonalization disorder, 2) Assess the durability of treatment response in these patients, 3) Assess the improvement in psychiatric disability in these patients, and 4) Assess the effects of comorbid Axis I disorders (depression, social phobia, panic/anxiety, obsessive-compulsive disorder) and Axis II personality disorders on treatment outcome in these patients.

Timeline

Start
1998-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule